The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting ...
These are the conversations taking centre stage at the MAD World Summit 2026, the UK’s leading event dedicated to workplace ...
Trixeo/Breztri, is approved in the US for treatment of asthma, with regulatory filings currently under review in other major ...
ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, has appointed Hitesh ...
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than ...
A supplemental New Drug Application (sNDA) for Pfizer’s Talzenna (talazoparib) in combination with Xtandi (enzalutamide) has ...
Takeda has announced new data from the two pivotal phase 3 studies of zasocitinib (TAK-279) in adults with moderate-to-severe ...
Chapple has held senior leadership roles at DontBePatient Intelligence, Alira Health, Innovative Trials, Cognizant and ICON ...
Almirall’s submission to extend its Marketing Authorisation Application (MAA) for Ebglyss (lebrikizumab) to treat moderate-to ...
Independent network The Bloc has appointed Jon Chapman as European Executive Creative Director. Chapman previously held ...
How do we translate individual experiences into support that helps others and create support that feels personal but remains ...
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results